- Associated Press - Tuesday, February 11, 2014

KANSAS CITY, Mo. (AP) - A New Jersey-based life sciences company is planning a $30 million expansion in Kansas City and the addition of 230 jobs in the next five years.

Catalent Pharma Solutions is involved with development of drugs, biologics and consumer health products. It has more than 1,000 scientists and 30 facilities on five continents, and works with most leading pharmaceutical and biologics marketers.

The Kansas City facility now has about 50 employees, working mainly on product development and analysis and clinical supply services.

Gov. Jay Nixon said Tuesday the expansion would strengthen Missouri’s position in biosciences. The state Department of Economic Development is offering $2.65 million of economic incentives for the company through the Quality Jobs program.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide